Brief: Heat Biologics Says Filed Provisional Patent Application That Applies Immune System Activating Technology For Treating/Preventing Infection With SARS-CoV-2 Virus That Causes COVID-19
02/03/2020 14:09
March 2 (Reuters) - Heat Biologics Inc HTBX.O :
* HEAT BIOLOGICS - FILED PROVISIONAL PATENT APPLICATION THAT
APPLIES IMMUNE SYSTEM ACTIVATING TECHNOLOGY FOR
TREATING/PREVENTING INFECTION WITH SARS-COV-2 VIRUS THAT CAUSES
COVID-19
Source text: (http://bit.ly/2VzjcJr)
Further company coverage: HTBX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Scorpius Holdings
See all newsBrief: Scorpius Holdings Inc Files For Non Timely 10-K With U.S. SEC
Brief: Scorpius Holdings Files For Offering Up To 29.4 Million Shares Of Common Stock
Brief: Scorpius Holdings Announces Collaboration With Celltheon Corporation
Brief: Scorpius Holdings - Implementation Of Strategic Cost-Saving Measures Expected To Save Over $2 Mln Annually
Brief: Scorpius Holdings Announces Partnership With U.S. Biotech Company